Quigley M A, Henderson G, Anthony M Y, McGuire W
University of Oxford, National Perinatal Epidemiology Unit, Old Road Campus, Oxford, UK, 0X3 7LF.
Cochrane Database Syst Rev. 2007 Oct 17(4):CD002971. doi: 10.1002/14651858.CD002971.pub2.
When sufficient maternal breast milk is not available, the alternative sources of enteral nutrition for preterm or low birth weight infants are donor breast milk or artificial formula milk. Feeding preterm or low birth weight infants with formula milk might increase nutrient input and growth rates. However, since feeding with formula milk may be associated with a higher incidence of feeding intolerance and necrotising enterocolitis, this may adversely affect growth and development.
To determine the effect of formula milk compared with donor human breast milk on growth and development in preterm or low birth weight infants.
The standard search strategy of the Cochrane Neonatal Review Group was used. This included electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 2007), MEDLINE (1966 - May 2007), EMBASE (1980 - May 2007), CINAHL (1982 - May 2007), conference proceedings, and previous reviews.
Randomised controlled trials comparing feeding with formula milk versus donor breast milk in preterm or low birth weight infants.
Data were extracted using the standard methods of the Cochrane Neonatal Review Group, with separate evaluation of trial quality and data extraction by two reviewer authors, and synthesis of data using relative risk, risk difference and weighted mean difference.
Eight trials fulfilled the inclusion criteria. Only one trial used nutrient-fortified donor breast milk. Enteral feeding with formula milk compared with donor breast milk resulted in higher rates of growth in the short term. There was no evidence of an effect on long-term growth rates or neurodevelopmental outcomes. Meta-analysis of data from five trials demonstrated a statistically significantly higher incidence of necrotising enterocolitis in the formula fed group: typical relative risk 2.5 (95% confidence interval 1.2, 5.1); typical risk difference: 0.03 (95% confidence interval 0.01, 0.06; number needed to harm: 33 (95% confidence interval 17, 100).
AUTHORS' CONCLUSIONS: In preterm and low birth weight infants, feeding with formula milk compared with donor breast milk results in a higher rate of short-term growth but also a higher risk of developing necrotising enterocolitis. There are only limited data on the comparison of feeding with formula milk versus nutrient-fortified donor breast milk. This limits the applicability of the findings as nutrient fortification of breast milk is now a common practice in neonatal care. Future trials may compare growth, development and adverse outcomes in infants who receive formula milk versus nutrient-fortified donor breast milk given as a supplement to maternal expressed breast milk or as a sole diet.
当无法获得充足的母乳时,早产或低体重婴儿的肠内营养替代来源是捐赠母乳或人工配方奶。用配方奶喂养早产或低体重婴儿可能会增加营养摄入和生长速度。然而,由于用配方奶喂养可能与喂养不耐受和坏死性小肠结肠炎的发生率较高有关,这可能会对生长发育产生不利影响。
确定与捐赠母乳相比,配方奶对早产或低体重婴儿生长发育的影响。
采用Cochrane新生儿综述组的标准检索策略。这包括对Cochrane对照试验中心注册库(CENTRAL,Cochrane图书馆,2007年第2期)、MEDLINE(1966年至2007年5月)、EMBASE(1980年至2007年5月)、CINAHL(1982年至2007年5月)、会议论文集和以往综述进行电子检索。
比较早产或低体重婴儿用配方奶喂养与捐赠母乳喂养的随机对照试验。
使用Cochrane新生儿综述组的标准方法提取数据,由两位综述作者分别评估试验质量和提取数据,并使用相对风险、风险差异和加权平均差异对数据进行综合分析。
八项试验符合纳入标准。只有一项试验使用了营养强化的捐赠母乳。与捐赠母乳相比,用配方奶进行肠内喂养在短期内导致更高的生长速度。没有证据表明对长期生长速度或神经发育结局有影响。对五项试验的数据进行的荟萃分析表明,配方奶喂养组坏死性小肠结肠炎的发生率在统计学上显著更高:典型相对风险为2.5(95%置信区间1.2,5.1);典型风险差异为0.03(95%置信区间0.01,0.06;伤害所需人数为33(95%置信区间17,100)。
在早产和低体重婴儿中,与捐赠母乳相比,用配方奶喂养导致短期生长速度更高,但发生坏死性小肠结肠炎的风险也更高。关于配方奶喂养与营养强化捐赠母乳喂养比较的数据有限。这限制了研究结果的适用性,因为母乳营养强化现在是新生儿护理中的常见做法。未来的试验可能会比较接受配方奶喂养的婴儿与接受营养强化捐赠母乳作为母亲挤出母乳的补充或作为唯一饮食的婴儿的生长、发育和不良结局。